Migraine News and Research

Latest Migraine News and Research

Antibody therapeutics targeting GPCRs to be developed by alliance between MorphoSys and Heptares

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.

13 Feb 2013

LASAG trial for severe influenza initiated

...

12 Feb 2013

Tips on avoiding a Valentine's Day Headache

February 14 is right around the corner, and no one wants to spend Valentine's day, or the day after, with a severe headache and some of its accompaniments – nausea, vomiting, sensitivity to light and sound. And you certainly don't want your gift to be the culprit in producing a headache.

12 Feb 2013

Valproate, pregnancy and IQ: an interview with Professor Kimford Meador

Valproate (sodium salt of valproic acid) is an anticonvulsant used in the treatment of epilepsy, migraine and bipolar disorder as well as some other off label psychiatric indications.

11 Feb 2013

Nerve stimulator may be new option for migraine sufferers

Wearing a nerve stimulator for 20 minutes a day may be a new option for migraine sufferers, according to new research published in the February 6, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 Feb 2013

Migraine, epilepsy and genetics: an interview with Dr. Melodie Winawer

This work is the product of an extraordinary consortium called the Epilepsy Phenome/Genome project (EPGP). It is a consortium of 27 centres in the U.S. and internationally with several hundred physicians and staff who have worked together to enrol more than 4000 patients with epilepsy and their family members.

7 Feb 2013

ATI Neurostimulation System demonstrates clinical effectiveness in treating cluster headache

Autonomic Technologies, Inc. (ATI), the developer of the ATI Neurostimulation System designed for the treatment of severe headaches, today announced results of their clinical study in cluster headache, now published online in Cephalalgia.

5 Feb 2013

Triggers linked to migraines with aura remain nebulous

Only a small fraction of patients who suffer from migraine with aura experience an attack when they are exposed to self-reported natural triggers in an experimental setting, research shows.

4 Feb 2013

Strong placebo response key to adolescent migraine trial failures

A strong response to placebo is the main reason drug trials in the treatment of adolescent migraine have so far failed, say researchers.

31 Jan 2013

Supplementation with omega-3 fatty acids promotes effective immune system response

Supplementation with omega-3 fatty acids promotes effective immune system response and has ameliorating effects on chronic inflammation (a condition caused by an imbalanced immune system that can lead to multiple serious illnesses over time), according to the most recent study published by the National Center for Biotechnology Information on the effects of omega-3.

31 Jan 2013

Pediatric migraine drugs show limited or no efficacy

There is limited evidence supporting the efficacy of trazodone and topiramate in the prevention of pediatric episodic migraine headaches, show results from a meta-analysis.

30 Jan 2013

Childhood adversity raises comorbidity risk in bipolar disorder

Childhood adversity, including verbal, physical, or sexual abuse, is associated with the later development of multiple medical comorbidities in patients with bipolar disorder, researchers report.

29 Jan 2013

Lightning may affect the onset of headache and migraines

University of Cincinnati (UC) researchers have found that lightning may affect the onset of headache and migraines.

25 Jan 2013

Neuromuscular blockade (NMB) reversal

General anesthesia is made up of three components: hypnotic medicines, to induce sleep; analgesics, or medicines to inhibit pain; and NMB agents that induce muscle relaxation. Anesthesiology professionals use NMB to relax a patient’s muscles and prevent involuntary movement that could impact surgery.

24 Jan 2013

FDA approves Allergan’s BOTOX to treat overactive bladder

Allergan, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BOTOX (onabotulinumtoxinA) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency in adults who have had an inadequate response to or are intolerant of an anticholinergic medication.

19 Jan 2013

Athletes with concussions in early adulthood may be at increased risk of depression as they age

National Football League (NFL) players may be at increased risk of depression as they age due to brain damage resulting from concussions, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

Women who have migraine with aura more likely to develop major cardiovascular events

Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

Study: Social stigma of chronic migraine and epilepsy are similar

A groundbreaking study lead by William B. Young, MD, a neurologist at Thomas Jefferson University Hospital's Headache Center, shows that patients with migraine (a combination of severe headache, nausea, light sensitivity, and other factors) suffer social stigma from their disease similar to the stigma experienced by patients with epilepsy.

17 Jan 2013

People most often visit doctors because of skin issues, joint disorders and back pain

A new Mayo Clinic Proceedings study shows that people most often visit their health care providers because of skin issues, joint disorders and back pain. Findings may help researchers focus efforts to determine better ways to prevent and treat these conditions in large groups of people.

17 Jan 2013

Stroke survivors with depression more likely to die

People who are depressed after a stroke may have a tripled risk of dying early and four times the risk of death from stroke than people who have not experienced a stroke or depression, according to a study that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

16 Jan 2013

Migraine News and Research

Latest Migraine News and Research

Antibody therapeutics targeting GPCRs to be developed by alliance between MorphoSys and Heptares

LASAG trial for severe influenza initiated

Tips on avoiding a Valentine's Day Headache

Valproate, pregnancy and IQ: an interview with Professor Kimford Meador

Nerve stimulator may be new option for migraine sufferers

Migraine, epilepsy and genetics: an interview with Dr. Melodie Winawer

ATI Neurostimulation System demonstrates clinical effectiveness in treating cluster headache

Triggers linked to migraines with aura remain nebulous

Strong placebo response key to adolescent migraine trial failures

Supplementation with omega-3 fatty acids promotes effective immune system response

Pediatric migraine drugs show limited or no efficacy

Childhood adversity raises comorbidity risk in bipolar disorder

Lightning may affect the onset of headache and migraines

Neuromuscular blockade (NMB) reversal

FDA approves Allergan’s BOTOX to treat overactive bladder

Athletes with concussions in early adulthood may be at increased risk of depression as they age

Women who have migraine with aura more likely to develop major cardiovascular events

Study: Social stigma of chronic migraine and epilepsy are similar

People most often visit doctors because of skin issues, joint disorders and back pain

Stroke survivors with depression more likely to die

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Migraine News and Research

Latest Migraine News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in